BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao M, Shen X, Li X, Chen B, Fan L, Xia Q, Zhao L. Chitooligosaccharide supplementation prevents the development of high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in mice via the inhibition of cluster of differentiation 36 (CD36). Journal of Functional Foods 2019;57:7-18. [DOI: 10.1016/j.jff.2019.03.048] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Ji X, Chen M, Zhao M, Song Y, Lin Y, Yin H, Zhao L. Effects of chitooligosaccharides on the rebalance of gut microorganisms and their metabolites in patients with nonalcoholic fatty liver disease. Journal of Functional Foods 2021;77:104333. [DOI: 10.1016/j.jff.2020.104333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Huang Z, Chen M, Guo W, Li T, Liu B, Bai W, Ai L, Rao P, Ni L, Lv X. Monascus purpureus-fermented common buckwheat protects against dyslipidemia and non-alcoholic fatty liver disease through the regulation of liver metabolome and intestinal microbiome. Food Research International 2020;136:109511. [DOI: 10.1016/j.foodres.2020.109511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Liu P, Li H, Li R, Geng Y, Gong J, Xu H, Xu Z, Shi J. Nanoencapsulation of chitooligosaccharides enhances its oral bioavailability and anti-liver fibrotic effects. Food Research International 2022. [DOI: 10.1016/j.foodres.2022.111471] [Reference Citation Analysis]
4 Hu X, Chen S, Yin H, Wang Q, Duan Y, Jiang L, Zhao L. Chitooligosaccharides-modified PLGA nanoparticles enhance the antitumor efficacy of AZD9291 (Osimertinib) by promoting apoptosis. International Journal of Biological Macromolecules 2020;162:262-72. [DOI: 10.1016/j.ijbiomac.2020.06.154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu P, Li H, Gong J, Geng Y, Jiang M, Xu H, Xu Z, Shi J. Chitooligosaccharides alleviate hepatic fibrosis by regulating the polarization of M1 and M2 macrophages. Food Funct 2021. [PMID: 34940780 DOI: 10.1039/d1fo03768d] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ji X, Chang K, Chen M, Zhu L, Osman A, Yin H, Zhao L. In vitro fermentation of chitooligosaccharides and their effects on human fecal microbial community structure and metabolites. LWT 2021;144:111224. [DOI: 10.1016/j.lwt.2021.111224] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
7 Luo S, Qin Z, Chen Q, Fan L, Jiang L, Zhao L. High level production of a Bacillus amlyoliquefaciens chitosanase in Pichia pastoris suitable for chitooligosaccharides preparation. Int J Biol Macromol 2020;149:1034-41. [PMID: 32027900 DOI: 10.1016/j.ijbiomac.2020.02.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
8 Lv X, Chen M, Huang Z, Guo W, Ai L, Bai W, Yu X, Liu Y, Rao P, Ni L. Potential mechanisms underlying the ameliorative effect of Lactobacillus paracasei FZU103 on the lipid metabolism in hyperlipidemic mice fed a high-fat diet. Food Research International 2021;139:109956. [DOI: 10.1016/j.foodres.2020.109956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
9 Huang Z, Deng J, Li Q, Cao Y, Lin Y, Bai W, Liu B, Rao P, Ni L, Lv X. Protective Mechanism of Common Buckwheat ( Fagopyrum esculentum Moench.) against Nonalcoholic Fatty Liver Disease Associated with Dyslipidemia in Mice Fed a High-Fat and High-Cholesterol Diet. J Agric Food Chem 2020;68:6530-43. [DOI: 10.1021/acs.jafc.9b08211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 Shen X, Liang X, Ji X, You J, Zhuang X, Song Y, Yin H, Zhao M, Zhao L. CD36 and DGAT2 facilitate the lipid-lowering effect of chitooligosaccharides via fatty acid intake and triglyceride synthesis signaling. Food Funct 2021. [PMID: 34351342 DOI: 10.1039/d1fo01472b] [Reference Citation Analysis]
11 Li HY, Peng ZG. Targeting lipophagy as a potential therapeutic strategy for nonalcoholic fatty liver disease. Biochem Pharmacol 2022;197:114933. [PMID: 35093393 DOI: 10.1016/j.bcp.2022.114933] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]